Analysis of Characteristics Among Users of Tami, a Digital Companion for Managing Inflammatory Bowel Disease
-
By
-
Ann-Sophie Stratil
-
Benjamin Friedrich
-
Tim Hahn
-
Andreas Lügering
-
Steffeni Papukchieva
-
February 1, 2026
Clinical Scorecard: Analysis of Characteristics Among Users of Tami, a Digital Companion for Managing Inflammatory Bowel Disease
At a Glance
| Category | Detail |
|---|
| Condition | Inflammatory Bowel Disease (IBD) |
| Key Mechanisms | Persistent inflammation in the gastrointestinal tract leading to various symptoms and complications. |
| Target Population | Adults aged 18 and older diagnosed with IBD. |
| Care Setting | Digital health management through a smartphone application. |
Key Highlights
- Tami app allows users to track symptoms and health-related quality of life.
- Users can monitor medication use and receive personalized health guidance.
- Study aims to link patient-reported outcomes with disease activity and treatment responses.
Guideline-Based Recommendations
Diagnosis
- Users select their IBD diagnosis from options including Crohn's disease, ulcerative colitis, and indeterminate colitis.
Management
- Medication use is tracked, with options limited to approved treatments for the selected diagnosis.
Monitoring & Follow-up
- Daily tracking of symptoms and patient-reported outcomes is encouraged.
Risks
- Potential complications of IBD include perforation, fistula, and abscess formation.
Patient & Prescribing Data
Registered Tami users aged 18 and older.
Users can select medications from conventional, advanced, and other categories.
Clinical Best Practices
- Encourage regular symptom and PRO tracking for personalized treatment strategies.
- Utilize digital tools for ongoing patient engagement and support.
Related Resources & Content
